Provided by Tiger Trade Technology Pte. Ltd.

Royalty Pharma plc

46.35
-0.5900-1.26%
Post-market: 46.350.00000.00%18:10 EDT
Volume:2.71M
Turnover:126.39M
Market Cap:27.03B
PE:26.02
High:47.33
Open:47.00
Low:46.06
Close:46.94
52wk High:47.86
52wk Low:29.66
Shares:583.17M
Float Shares:379.85M
Volume Ratio:0.64
T/O Rate:0.71%
Dividend:0.88
Dividend Rate:1.90%
EPS(TTM):1.78
EPS(LYR):1.78
ROE:13.20%
ROA:5.15%
PB:4.17
PE(LYR):26.02

Loading ...

A Look at Royalty Pharma’s (RPRX) Valuation Following Upgraded Guidance and Buybacks

Simply Wall St.
·
Nov 07, 2025

Stock Track | Royalty Pharma Soars 5.02% on Strong Q3 Results and Raised Guidance

Stock Track
·
Nov 05, 2025

Royalty Pharma Q3 Portfolio Receipts up 11%, guidance raised

Reuters
·
Nov 05, 2025

Royalty Pharma Q3 Adj. EPS $1.17 Beats $1.04 Estimate, Sales $609.000M Miss $739.257M Estimate

Benzinga
·
Nov 05, 2025

Royalty Pharma Q3 Adjusted Ebitda USD 779 Million

THOMSON REUTERS
·
Nov 05, 2025

Royalty Pharma : Raised Full Year 2025 Guidance: Portfolio Receipts Expected to Be $3,200 to $3,250 Mln

THOMSON REUTERS
·
Nov 05, 2025

Royalty Pharma Buys $310 Million AMVUTTRA Royalty from Blackstone

Reuters
·
Nov 04, 2025

Royalty Pharma Keeps Quarterly Dividend at $0.22 a Share, Payable Dec. 10 to Holders of Record on Nov. 14

MT Newswires Live
·
Oct 17, 2025

Royalty Pharma plc Announces $0.22 Dividend for Q4 2025

Reuters
·
Oct 17, 2025

Citi Sticks to Its Buy Rating for Royalty Pharma (RPRX)

TIPRANKS
·
Oct 13, 2025

Royalty Pharma Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Oct 11, 2025

Royalty Pharma plc to announce third quarter 2025 financial results

Reuters
·
Oct 10, 2025

Zenas BioPharma Announces $120 Million Private Placement to Support Global Expansion and Development Programs

Reuters
·
Oct 08, 2025

Royalty Pharma: Strategic Positioning and Growth Potential Drive Buy Rating

TIPRANKS
·
Oct 02, 2025

Royalty Pharma Initiated at Buy by Goldman Sachs

Dow Jones
·
Sep 30, 2025

Royalty Pharma Appoints DR. Ted W. Love as Lead Independent Director

THOMSON REUTERS
·
Sep 29, 2025

Press Release: Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director

Dow Jones
·
Sep 29, 2025